Share Name Share Symbol Market Type Share ISIN Share Description
Emis Group LSE:EMIS London Ordinary Share GB00B61D1Y04 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 761.00p 757.00p 761.00p 771.00p 747.00p 770.00p 40,510 16:29:58
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 158.7 25.3 30.4 25.0 481.80

Emis Share Discussion Threads

Showing 451 to 474 of 475 messages
Chat Pages: 19  18  17  16  15  14  13  12  11  10  9  8  Older
DateSubjectAuthorDiscuss
21/2/2018
12:34
Some more detail from NHS Wales; To: GP practices using EMIS computer systems 9 February 2018 Dear Colleague GMS Systems Framework Contract Procurement Following on from our letter dated 29th January 2018 we are writing to you with more information about the decision regarding EMIS Health Ltd. We recognise that changing supplier is a very significant undertaking and it is disappointing that EMIS Health Ltd submitted a response that fell far short of the requirements despite considerable dialogue at every stage explaining why their proposed changes to the NHS Wales requirements would not be acceptable. This position was not consistent with the responses from Vision (InPractice Systems Ltd) and Microtest Ltd, who were appointed onto the Framework. The procurement evaluation focussed on ensuring that each supplier offered a system that met the minimum functional requirements, in addition to the wider support, service levels, integration with the Welsh technical platform, affordability, value for money and very importantly the acceptance of risk. These requirements reflect the current GP Practice needs as well as commitment to meet future developments. The requirements that EMIS Health Ltd did not commit to meet are broadly those which they are already signed up to within their current contract with NHS Wales. Please be assured that NHS Wales offered every opportunity to all suppliers to meet the published requirements. This included awareness of the likely consequences of not fully meeting the requirements and not agreeing to the standard terms and conditions, which are used extensively across the UK for major IT contracts. In broad terms the changes EMIS Health Ltd requested would, in the judgement of the GMS IM & T Programme Board's Procurement Executive Committee, have left no significant levers to remedy system failures and malfunctions in an appropriate timescale leading to unacceptable risk transfer, both financial and professional, to practices (and NHS Wales). In addition, at a time when Welsh Government and the BMA are looking at a possibly radical revision of the GMS contract, EMIS Health Ltd were unwilling to sign up to any mandatory system changes required to support any such new contract. This was clearly unacceptable in terms of strategic changes to make the GMS contract fit for the future. Lastly a number of key add-ons including full DocMan functionality would have been at extra cost to the practice rather than included as per the agreed requirements. Cumulatively, there were too many areas where EMIS Health Ltd only partially met the requirements or made too many changes to the contract drafting, which had a detrimental effect on, or increased the risk position of, NHS Wales. Further information is available in the accompanying Frequently Asked Questions. However, key areas of concern related to:  EMIS Health Ltd would not commit to the required service levels and resolution of system problems  EMIS Health Ltd reserved the right to charge extra and defer delivery of a number of core functional requirements  EMIS Health Ltd reserved the right to reject requests for any future changes in the system  EMIS Health Ltd imposed restrictions on NHS Wales’ ability to manage the supplier to deliver the required availability and performance At this stage we want to provide further reassurance that resources will be available throughout the transition period to help each practice change supplier. We will also consider the impact of any third party software compatibility issues to try and mitigate any disadvantage to practices. A Stakeholder Reference Group will be established to help develop the support package and agree the best mechanisms to help practices through the migration process. If you are interested in participating in this group or have any further queries regarding the procurement please email pct@wales.nhs.uk.
wad collector
20/2/2018
13:21
From 3 weeks ago ; Give shares in EMIS Group a miss, said the Sunday Times' Inside the City column. The AIM-listed software specialist, which was founded by two doctors in 1987, supplier software services including those for keeping patient records, drug ordering and connecting different primary care services, as well as setting up GPs' websites, IT infrastructure and web hosting. The balance sheet had net cash of £14.0m cash and is a strong cash generator. Earlier in January, however, EMIS revealed that chief executive Andy Thorburn, who joined last May, had conducted a review of customer and product support processes and identified "a failure to meet certain service levels and reporting obligations" with a GP product supplied on a contract with NHS Digital. The financial impact was estimated "in the order of upper single digits of millions of pounds" and said the company will update the market as appropriate. Analysts at house broker Numis said the key issues have been uncovered and that it is unlikely it was done for personal financial gain. However, the analysts predict rectifying the issue will result in higher costs, not ideal in a market where the company faces tough competition and the ongoing NHS cash squeeze. There are also "curious signs" in its accounts, says the column, with outstanding receivables, where revenue has been booked but cash has not yet been received, rising to 15% of revenue in 2016 from 3% five years before.
wad collector
05/2/2018
16:39
hxxps://www.gponline.com/half-gp-practices-wales-face-system-switch/article/1455838 "The changes EMIS wanted to implement would have put practices at unacceptable risk of disruption, and included no levers to protect practices operationally if the system were to collapse.' I see it was Vision and Microtest who won the contract. I suspect there are a lot of unspoken agendas at play here. Losing customers with that statement is not good for EMIS's image even if the profit margins are less in Wales.
wad collector
30/1/2018
23:06
Usually this kind of statement occurs when a competitor has bought the business at an uncompetive rate so it’s probably better to lose it rather than run with something marginally profitable
boll
30/1/2018
19:23
Grahamburn Believe me - EMIS will have wanted to retain this business. The question is why they were not able to do so. Not sure who their replacement is but I can guess the reasons - integration either with Hospitals, Councils or both.
gopher
30/1/2018
09:27
Only query is did EMIS really want the business in Wales (ie was it viable)? Note the reference to "margin significantly below the Group average". Maybe EMIS didn't try that hard to retain it.
grahamburn
30/1/2018
08:02
Looks like the business moat isn't as wide as I thought: Update re: NHS Wales GP framework agreement EMIS Group plc has received confirmation from NHS Wales that it has not been chosen as a preferred vendor for the next primary care framework agreement in Wales, following a planned procurement review process which began during the first quarter of 2017, as previously reported by the Group. As at 30 June 2017, EMIS provided GP services to 195 practices in Wales. The Group's total UK estate at that date was 5,147 GP practices. Annual revenues from the existing framework agreement with NHS Wales are approximately £2 million at a margin significantly below the Group average. This decision will require that EMIS Web users in Wales are transitioned to a new provider via a phased process throughout 2019 and 2020, to be agreed with NHS Wales. EMIS will continue to generate revenues on a reducing basis until the transition process is complete.
eagle eye
25/1/2018
16:49
Decided to buy a few shares just before closing and managed to get sub 770p. I still think EMIS are a little overvalued, considering they are pretty well ex-growth now. But relative to the general market they no longer look that expensive, especially when compared to how over-valued they were for a long period when the PER was in the high 20s. I don't think we'll see this back in the 900s for a while, but the high 800s seems achievable over the next year or so, pending no disasters.
bend1pa
23/1/2018
12:49
Some good questions in that blog ; "I would like to receive more information about the nature of the contracts that have resulted in the large potential liability. I understand you are still assessing the potential liability but the announcement should really have spelled out the nature of the commitments that seem to have been made by the company previously, and which have not been adhered to. I am also surprised that such a large liability is being announced when no apparent claim has been received (at least none is indicated), and no financial loss to the third party concerned is being reported. I also question why the potential liability and risks associated with the relevant contracts were not disclosed in the Annual Report for the year ending December 2016. Indeed there is extensive discussion of “risk” in the business in that document and the risks the business face were apparently reviewed in that year by the board of directors. The risks of all kinds were generally reported as “low”, when it seems that a major undisclosed risk was being run. One could also question why the audit by KPMG failed to identify this apparently major defect in the company’s systems and accounting for the liability. Did they not review this aspect of the company’s activities? Lastly there is no indication in the announcement as to how long this failure which has caused the potential liability has been going on. Perhaps you could answer that question, and also indicate whether it may be necessary to restate past accounts.”
wad collector
21/1/2018
10:57
There is a recent blog post on Emis available here: hTTps://www.sharesoc.org/blog/insolvency-and-administration/carillion-emis-kpmg/
sharesoc
18/1/2018
23:01
would have thought that private equity might now be tempted to pounce on EMIS; they might feel they could do a better management job in a company with a commanding market share of gp's software.
mw8156
18/1/2018
22:09
Not to serious imo but embarrassing for Company. The way these contracts are calculated can be complicated and EMIS have made a mistake
gopher
18/1/2018
20:42
According to the Yorkshire Post report, the problem relates to low level software glitches such as patients receiving multiple SMS text messages and reminders about their GP appointments-I'm thankful that I don't have a mobile phone! also mentions that the market for software professionals in Leeds is v competitive so they may have had recruitment/retention problems? doesn't sound too bad at all on the face of it but there is bound to be some reputational damage and the full extent of the problem may not yet have be known or have been revealed but so far reasonably encouraging?
mw8156
18/1/2018
19:36
Try to take it easy. We won't be chasing them as 1. The problem is usually just slowness in the system and frequent freezing - it is hard to quantify . and better 2. We don't pay the bill; our CCG does! Mikett agree on the latter , not sure about the former ; the hassle of changing also means that changing to EMIS is also a big step and some areas are dominated by other systems. When I first started using EMIS there were about 70 different GP systems in the UK.
wad collector
18/1/2018
15:37
I see this as a buying opportunity. Emis will IMO eventually be the system for all of primary care in England. The reason for this is it is much easier to transfer documents and information to the same system. Several regions have every practice using EMIS. It has been quite slow on several occasions recently, so they need to work on this. But barring an absolute shocker, the chances of GP practices moving away Fromm EMIS are extremely low. For a practice to switch to another provider is a logistical nightmare.
mikett1
18/1/2018
13:24
wad collector - thanks for your input. Will you be compensated for the disruption from EMIS? Have they said they will improve the service level? If I was in your shoes or someone else's I probably wouldn't move as how do you know anyone else will be better? The disruption as you say would be significant.
trytotakeiteasy
18/1/2018
13:24
wad collector - thanks for your input. Will you be compensated for the disruption from EMIS? Have they said they will improve the service level? If I was in your shoes or someone else's I probably wouldn't move as how do you know anyone else will be better? The disruption as you say would be significant.
trytotakeiteasy
18/1/2018
13:21
seems to me that they've rather taken their leadership position in primary care for granted and become complacent while chasing opportunities elsewhere; time now to knuckle down and concentrate on protecting their position and providing a good service.
mw8156
18/1/2018
13:11
The dual announcement was a bit duplicitous ; I read the trading statement and couldn't see why the share price plunged. To say "in line" with one breath and a multimillion pound unexpected hit with the next is misleading in my view and unlikely to be viewed as honest by a now suspicious market. I am an EMIS user and have seen more instability recently than most yrs but am not a big enough sample size to comment on the wider picture. Changing IT provider would be a very big deal to us , as the changes are very disruptive to the practice as business carries on and we are used to the system. It would take a much bigger service problem for us to seriously consider a change.
wad collector
18/1/2018
12:31
From Investors Chronicle daily round up: EMIS’ (EMIS) strategy to separate its good and bad news into two different announcements has not fooled investors. Shares in the healthcare software provider fell 17 per cent in early trading on the revelation that its Web product for GPs in England has failed to meet certain services levels and reporting obligations. The financial impact of this problem is expected to be “in the order of upper digits of millions of pounds”, according to management, who are working with NHS Digital to assess the full scale of the impact and attempt to resolve the matter. The group’s second update - an inline trading statement - made for much more pleasant reading, but after taking into account the one-off charge broker Numis has slashed its 2018 guidance. If the problems with Web products can be restricted to one off costs this morning’s share price fall presents an excellent buying opportunity, but we place our recommendation under review for now as we await more details on the extent of the damage.
grahamburn
18/1/2018
12:14
Though this a serious issue, especially regard to profit and reputation, it isn't clear whether the hit to profit is also a hit to the cash pile or whether some of it is non-cash. Need to await the results of the full investigation.
grahamburn
18/1/2018
11:57
agree, very disappointing in what should be a fairly easily managed service level contract one might think,can't get the staff?, no doubt damage incurred to their reputation and publicity, which inevitably follows when anything goes wrong in the NHS, could be very bad.
mw8156
18/1/2018
10:20
Disappointing. Worth stating that they have £14m net cash and so say a £9m charge would still leave net cash of £5m. The P/E ratio after the decline today will also have fallen back. It isn't clear if the issues will impact future customer relationships in EMIS's key division. Interesting that someone posted here in the medical profession that EMIS's GP system had become very patchy. On face value surely the circa £90m loss of market value is a bit overdone i.e. compares to the expected loss of up to £9m due to the service issues. EMIS is cash generative and so should build up its net cash position going forward. I am pretty disappointed with the company though. There job is to provide a key service to GP services and they failed to make it reliable. Not sure why or whether it has been rectified going forward or if GP surgeries will consider moving to competitors??
trytotakeiteasy
14/12/2017
09:48
Tenner breached albeit briefly , a 1 yr high . Long for me.
wad collector
Chat Pages: 19  18  17  16  15  14  13  12  11  10  9  8  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180225 18:00:54